PetMed Express Inc (PETS) stock
PETSNasdaqRetail-Drug Stores and Proprietary StoresFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3068% below fair value
$0.90+0.00 (+0.20%)
Close on Nov 17, 2026Market cap $19.50MP/E –Yield 0.00%
PetMed Express operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
PetMed Express's operating income for the twelve months ending Jun 30, 2026 was -$30.77M. For fiscal 2026 it was -$58.67M. The highest annual figure on record is $52.14M in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$58.67M | – |
| FY2025 | Mar 31, 2025 | -$1.53M | – |
| FY2024 | Mar 31, 2024 | -$8.16M | -234.9% |
| FY2023 | Mar 31, 2023 | $6.05M | -75.1% |
| FY2022 | Mar 31, 2022 | $24.29M | -20.4% |
| FY2021 | Mar 31, 2021 | $30.53M | -1.4% |
| FY2020 | Mar 31, 2020 | $30.98M | -32.9% |
| FY2019 | Mar 31, 2019 | $46.17M | -11.4% |
| FY2018 | Mar 31, 2018 | $52.14M | +39.1% |
| FY2017 | Mar 31, 2017 | $37.48M | +15.7% |
| FY2016 | Mar 31, 2016 | $32.39M | +17.3% |
| FY2015 | Mar 31, 2015 | $27.61M | -2.1% |
| FY2014 | Mar 31, 2014 | $28.22M | +4.5% |
| FY2013 | Mar 31, 2013 | $27.01M | +3.8% |
| FY2012 | Mar 31, 2012 | $26.02M | -21.2% |
| FY2011 | Mar 31, 2011 | $33.02M | -18.5% |
| FY2010 | Mar 31, 2010 | $40.54M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$6.23M | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$5.69M | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$10.47M | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$8.38M | -1612.6% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$34.13M | -878.2% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$6.02M | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$450.00K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $554.00K | -36.7% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $4.39M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$3.84M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$3.07M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $875.00K | -76.5% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$2.13M | -164.3% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$212.00K | -103.0% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$769.00K | -114.9% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $3.72M | -54.0% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $3.31M | -38.9% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $7.06M | -15.9% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $5.15M | -44.6% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $8.09M | -22.8% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $5.42M | -42.6% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $8.39M | -1.5% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $9.29M | +17.2% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $10.47M | +25.1% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $9.44M | +53.2% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $8.51M | +9.1% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $7.93M | -15.7% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $8.37M | -36.6% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $6.16M | -60.9% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $7.80M | -44.3% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $9.41M | -17.9% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $13.20M | +7.8% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $15.76M | +9.3% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $14.00M | +19.7% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $11.47M | +49.8% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $12.25M | +58.4% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $14.42M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $11.70M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $7.66M | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $7.73M | – |
See a number that looks wrong?